Michal Marczyk

Adjunct Assistant Professor

Yale University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michal Marczyk is an Adjunct Assistant Professor at Yale University School of Medicine in the United States. His research areas encompass histopathology, synthetic data preparation for multi-object detection, and the molecular analysis of breast cancer. He has recently contributed to articles exploring techniques for improving tumor heterogeneity quantification and assessing treatment responses in various cancer types.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

Daniel Danielsson

Karolinska University Hospital

SWEDEN

View details

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Roman Jaksik

Assistant Professor

Silesian University of Technology

POLAND

View details

Anna Papiez

Assistant professor

Silesian University of Technology

POLAND

View details

Dorota Scieglinska

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michal Marczyk

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

EPIIC: Edge-Preserving Method Increasing Nuclei Clarity for Compression Artifacts Removal in Whole-Slide Histopathological Images

Searching for the Ideal Recipe for Preparing Synthetic Data in the Multi-Object Detection Problem

EpidermaQuant: Unsupervised Detection and Quantification of Epidermal Differentiation Markers on H-DAB-Stained Images of Reconstructed Human Epidermis

Combining Low-Dose Computer-Tomography-Based Radiomics and Serum Metabolomics for Diagnosis of Malignant Nodules in Participants of Lung Cancer Screening Studies

Quantifying Spatial Heterogeneity of Tumor-Infiltrating Lymphocytes to Predict Survival of Individual Cancer Patients

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.

Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples.

GaMRed - Adaptive Filtering of High-Throughput Biological Data

Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer

Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

Technical Validity of a Customized Assay of Sensitivity to Endocrine Therapy Using Sections from Fixed Breast Cancer Tissue.

Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.

Immunological differences between immune-rich estrogen receptor-positive and immune-rich triple-negative breast cancers

Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden.

Collaborators (11)

Daniel Danielsson

Annika Bendes

Karol Jelonek

Joanna Zyla

Andrzej Polanski

Joanna Polanska

Pawel Foszner

Agata Kurczyk

Roman Jaksik

Anna Papiez

Dorota Scieglinska

Make your next move.